Kelly Dunn Named Inaugural Director of University of Maryland Kahlert Institute for Addiction Medicine
The University of Maryland School of Medicine (UMSOM) appointed Kelly Dunn, PhD, MBA, one of the nation’s leading researchers on opioid use disorder, as its...
The University of Maryland School of Medicine (UMSOM) appointed Kelly Dunn, PhD, MBA, one of the nation’s leading researchers on opioid use disorder, as its inaugural Director of the School’s Kahlert Institute for Addiction Medicine. Dr. Dunn will also serve as a Professor in the UMSOM’s Department of Psychiatry with a secondary appointment in the Department of Neurobiology.
Previously, Dr. Dunn was a Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine with a joint appointment in Health Policy and Management at the Johns Hopkins University School of Public Health. She has held multiple leadership roles in the substance use field, including serving as President for the American Psychological Association’s Society for Psychopharmacology and Substance Use and the College on the Problems of Drug Dependence (CPDD) as well as Co-Editor of the Journal of Addiction Medicine and Editor-in-Chief of the journal Experimental and Clinical Psychopharmacology. She has authored more than 130 peer-reviewed publications in the area of substance use and opioid use disorder, and has been the Principal Investigator on projects totaling more than $21 million in awards from the National Institutes of Health.
The Kahlert Institute for Addiction Medicine, launched in 2023 with a major gift from the Kahlert Foundation, is uniquely positioned to bring together leading addiction experts from across basic science and clinical care to transform the prevention, treatment, education, and research of addiction.
“Dr. Dunn’s current work in the field is impressive,” said Greg Kahlert, President of The Kahlert Foundation. “I am confident with her experience, passion and collaborative spirit, she will help find treatments and cures for those suffering from addiction. I could not be more excited that she is the first director of the Kahlert Institute for Addiction Medicine.”
WittKieffer’s Joyce De Leo, PhD, Kim Smith, and Katie Haddock led this search.
Related Articles
